Globus Medical Q1 FY26 GAAP EPS rises 66.6% to 0.90; net sales increase 27% to 759.9 million

Globus Medical Inc Class A

Globus Medical Inc Class A

GMED

0.00

  • Globus Medical posted first-quarter net income of USD 124.3 million, up 64.7%, with diluted EPS rising 66.6% to USD 0.90.
  • Net sales climbed 27% to USD 759.9 million, including USD 82.7 million from Nevro; base business net sales rose 13.2% to USD 677.2 million.
  • Operating income increased to USD 150.4 million, lifting net income margin to 16.4% from 12.6%.
  • Management cited organic growth above 13% led by core spine share gains and procedural volume strength, with Enabling Technologies expanding its customer base.
  • Full-year 2026 net sales outlook was reaffirmed at USD 3.18 billion to USD 3.22 billion, while non-GAAP diluted EPS guidance was raised to USD 4.70 to USD 4.80.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Globus Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605071615PRIMZONEFULLFEED9715737) on May 07, 2026, and is solely responsible for the information contained therein.